Flow cytometric detection of platelet activation in patients undergoing diagnostic and interventional coronary angiography

References

• Trip M D, Cats V M, van Capelle F JL, Vreeken J. Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N Engl J Med 1990; 322: 1549–54
   PubMed Web of Science ®Google Scholar
• Fitzgerald D J, Catella F, Roy L, Fitzgerald G A. Marked platelet activation after intravenous streptokinase in patients with acute myocardial infarction. Circulation 1988; 77: 142–50
   PubMed Web of Science ®Google Scholar
• Fitzgerald D J, Roy L, Catella F, Fitzgerald G A. Platelet activation in unstable coronary disease. N Engl J Med 1986; 315: 983–9
   PubMed Web of Science ®Google Scholar
• Ivanovich P, Hammerschmidt D E, Quintanilla A, Kishimoto T, Tanaka H, Levin N, Klinkmann H. Behaviour of platelets and beta-thromboglobulin. Nephrol Dial Transplant 1993; 8 Suppl 2: 15–9
   Google Scholar
• Abe S, Maruyama I, Arima S, Yamaguchi H, Okino H, Hamasaki S, Yamashita T, Nomoto K, Tahara M, Atsuchi Y. Platelet activation during thrombolysis and percutaneous transluminal coronary angioplasty in the acute phase of myocardial infarction. J Cardiol 1990; 20(4): 849–59
   Google Scholar
• Rinder C S, Bohnert J, Rinder H M, Michel J, Ault K, Hillman R. Platelet activation and aggregation during cardiopulmonary bypass. Anesthesiology 1991; 75(3): 388–93
   Google Scholar
• Ludlam C A. Assessment of platelet function. Haemostasis and Thrombosis, A L Bloom, C D Forbes, D P Thomas, E GD Tuddenham. Churchill Livingstone, Edinburgh 1994; 199–215
   Google Scholar
• Niewiarowski S. Secreted platelet proteins. Haemostasis and Thrombosis, A Bloom, C D Forbes, D P Thomas, E GD Tuddenham. Churchill Livingstone, Edinburgh 1994; 167–81
   Google Scholar
• Wu K K. Platelet activation and arterial thrombosis. Lancet 1994; 344: 991–5
   PubMedGoogle Scholar
• Shatil S J, Cunningham M, Hoxie J A. Detection of activated platelets in whole blood using activation dependent monoclonal antibodies and flow cytometry. Blood 1987; 70: 307–15
   Google Scholar
• Abrams C S, Ellison N, Brudzynski A Z, Shattil S J. Direct detection of activated platelets and platelet-derived microparticles in humans. Blood 1990; 75: 128–32
   PubMed Web of Science ®Google Scholar
• Scharf R E, Tomer A, Marzec U M, Tierstein P S, Ruggeri Z M, Harker L A. Activation of platelets in blood perfusing angioplasty-damaged arteries. Arterioscler Thromb 1992; 12: 1475–87
   PubMedGoogle Scholar
• Giles H, Smith R E, Martin J F. Platelet glycoprotein IIb-IIIa and size are increased in acute myocardial infarction. Eur J Clin Invest 1994; 24(1): 69–72
   Google Scholar
• Johnston G I, Pickett E B, McEver R P, George J N. Heterogeneity of platelets secretion in response to thrombin demonstrated by fluorescence flow cytometry. Blood 1987; 69: 1401–9
   PubMed Web of Science ®Google Scholar
• Nieuwenhuis H K, van Oosterhout J JG, Rozemueller E, van Iwaarden F, Sixma J J. Studies with a monoclonal antibody against activated platelets: Evidence that a secreted Mw 53000 lysosome-like-granule protein is exposed on the surface of activated platelets in the circulation. Blood 1987; 70: 838–42
   PubMed Web of Science ®Google Scholar
• Ault K A, Rinder H M, Mitchell J G, Rinder C S, Lambrew C T, Hillman R S. Correlated measurement of platelet release and aggregation in whole blood. Cytometry 1989; 10: 448–55
   PubMedGoogle Scholar
• Tschoepe D, Schultheiss H P, Kolarov P, Schwippert B, Dannehl K, Nieuwenhuis H K, Kehrel B, Strauer B, Gries F A. Platelet membrane activation markers are predictive for increased risk of acute ischemic events after PTCA. Circulation 1993; 88: 37–42
   PubMed Web of Science ®Google Scholar
• Forbes C D, Courtney J M. Thrombosis and artificial surfaces. Haemostasis and Thrombosis, A L Bloom, C D Forbes, D P Thomas, E GD Tuddenham. Churchill Livingstone, Edinburgh 1994; 1301–24
   Google Scholar
• Barradas M A, Mikhailidis D P, Epemolu O, Jeremy J Y, Fonseca V, Dandona P. Comparison of the platelet pro-aggregatory effect of conventional unfractionated heparins and a low molecular weight heparin fraction (CY 222). Br J Haematol 1987; 67: 451–7
   PubMed Web of Science ®Google Scholar
• Davidson C J, Mark D B, Pieper K S, Kisslo K B, Hlatky M A, Gabriel D A, Bashore T M. Thrombotic and cardiovascular complications related to nonionic contrast media during cardiac catheterization: analysis of 8517 patients. Am J Cardiol 1990; 65: 1481–4
   Google Scholar
• Hill J A, Grabowski E F. Relationship of anticoagulation and radiographic contrast agents to thrombosis during coronary angiography and antioplasty. Catheriz Cardiovasc Diag 1992; 25: 200–8
   Google Scholar
• Chronos N AF, Goodall A H, Wilson D J, Sigwart U, Buller N P. Profound platelet degranulation is an important side effect of some types of contrast media used in interventional cardiology. Circulation 1993; 88: 2035–44
   PubMed Web of Science ®Google Scholar
• Koza M J, Shankey T C, Walenga J M, Moncada R, Fareed J, Pifarre R. Flow cytometric evaluation of platelet activation by ionic or nonionic contrast media and modulation by heparin and recombinant hirudin. Invest Radiol 1995; 30: 90–7
   Google Scholar
• Benet J S, Vilaire G. Exposure of platelet fibrinogen receptors by ADP and epinephrine. J. Clin Invest 1979; 64: 1393–401
   Google Scholar
• Shattil S J, Hoxie J A, Cunningham M, Brass L F. Changes in the platelet membrane glycoprotein GP IIb-IIIa complex during platelet activation. J Biol Chem 1985; 260: 11107–14
   PubMed Web of Science ®Google Scholar
• Shattil S J, Brass L F. Induction of the fibrinogen receptor on human platelets by intracellular mediators. J Biol Chem 1987; 262: 992–99
   PubMed Web of Science ®Google Scholar
• Voss R, Geissler B S, Tillmanns H, Matthias F R. In vitro and ex vivo effects of aspirin in patients on a low-dose aspirin therapy. Thromb Res 1993; 72: 49–57
   PubMed Web of Science ®Google Scholar
• Burroughs S F, Johnson G J. β-lactam antibiotic-induced platelet dysfunction: evidence for irreversible inhibition of platelet activation in vitro and in vivo after prolonged exposure toenicillin. Blood 1990; 75: 1473–80
   PubMed Web of Science ®Google Scholar
• Langford E L, Brown A S, Wainwright R J, de Belder A J, Thomas M R, Smith R EA, Radomski M W, Martin J F, Moncada S. Inhibition of platelet activity by S-nitrosoglutathione during coronary angioplasty. Lancer 1994; 344: 1458–60
   PubMed Web of Science ®Google Scholar
• Rinder C S, Student L A, Bonan J L, Rinder H M, Smith B R. Aspirin does not inhibit adenosine diphosphate-induced platelet α-granule release. Blood 1993; 82: 505–12
   PubMed Web of Science ®Google Scholar
• Chronos N AF, Wilson D J, Janes S L, Hutton R A, Buller N P, Goodall A H. Aspirin does not affect the flow cytometric detection of fibrinogen binding to or release of α-granules of lysosomes from, human platelets. Clin Sci 1994; 87: 575–80
   PubMed Web of Science ®Google Scholar
• Terres W, Ham C W, Ruchelka A, Weilepp A, Kupper W. Residual platelet function under acetylsalicylic acid and the risk of restenosis after coronary angioplasty. J Cardiovasc Pharmacol 1992; 19(2)190–3
   Google Scholar
• Nurden A T, Macchi L, Bihour C, Durrieu C, Besse P, Nurden P. Markers of platelet activation in coronary heart disease. Eur J Clin Invest 1994; 24 Suppl 1: 42–5
   Google Scholar
• The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994; 330: 956–61.
   PubMed Web of Science ®Google Scholar